2004 Clinical Trials Treatment 
Greencamp
FEBRUARY 17, 2019
One study from 2004 looked at cannabinoids as a treatment option for managing bowel diseases symptoms (including IBS), because of their anti-inflammatory properties, but also the ability to diminish pain levels. Cannabis (more precisely its compound CBD), is a proven anti-inflammatory agent. ( How to choose the best strain for IBS?
Cannabis Law Report
JULY 6, 2021
Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist, an effective treatment for alcoholism. ” About Ehave, Inc. Ehave, Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Joint Blog
FEBRUARY 24, 2021
They made it clear that no evidence is available and that there are real potential risks to treatment. The effects were so promising that Parkinson’s UK began funding for the worlds first clinical trial. This trial would be used to assess whether or not CBD could treat the psychosis symptoms of Parkinson’s. 1] [link].
Greencamp
FEBRUARY 2, 2019
Drugs used for the treatment of HIV and AIDS are called antiretroviral medications, and there are several different classes of these drugs: Fusion/Entry Inhibitors (they prevent, or more precisely slow down HIV from entering healthy cells). But I haven’t seen any clinical trials looking at the direct effects of THC on the virus.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.
Cannabis Law Report
NOVEMBER 24, 2021
It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ).
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Expert insights. Personalized for you.
96 
Let's personalize your content